Specialized industry experts
Campbell Alliance Group, founded in 1997 by John Campbell, is
home to management consultants who are experts in the
biopharmaceutical and medical technology industries. Due to this
intense focus, the firm primarily hires consultants who have years
of experience working directly in biopharma or medical technology,
or as consultants to the industry.
That is not to say that there is no diversity in the experience
and expertise of the consultants at Campbell Alliance. The firm
recently consolidated it six main practice areas into three focused
Centers of Excellence (COE). The Commercial COE helps
maximize the commercial potential and value of individual product
assets and resources throughout the full product life cycle.
The Corporate Development COE helps clients build corporate and
portfolio growth strategies, as well as evaluate and integrate
transactions to enhance shareholder value. Lastly, the
Medical COE helps clinical and medical affairs leaders more
strategically deploy their resources and make their organizations
more efficient. It also provides strategic medical affairs
guidance at the product level.
While consultants primarily specialize in services related to
one COE, teams often times work together to solve a client's more
Under new ownership
The firm was acquired by inVentiv Health, Inc in February 2011.
A "leading global provider of best-in-class clinical, commercial
and consulting services to companies seeking to accelerate
performance," inVentiv's expanded implementation capabilities and
global reach mean that Campbell Alliance is a firm with endless
Aiming for client loyalty
Those clients who have worked with Campbell Alliance typically
come back for seconds. The firm boasts that about 85 percent of its
business comes from satisfied, repeat customers, and advertises
that its average score on customer satisfaction surveys is an
impressive 9.4 out of 10. And that feedback is coming from some of
the biggest players in the world of pharma: the firm's client list
includes all of the world's top-20 biopharmaceutical companies,
hundreds of emerging and midsize firms, as well as numerous medical
device and diagnostic companies.